A huge pharmaceutical merger is off: Pfizer of New York has put a halt to a $160 billion deal with Allergan of Ireland. Pfizer was after Allergan’s Irish street address so it could lower its U.S. taxes in a maneuver known as an inversion. That changed after the U.S. government decided to clamp down on tax-inversion rules on Tuesday.
Don’t be surprised, though, if someone tries to challenge these new rules.
“Who knows if someone’s going to go running to court saying that the Treasury secretary has exceeded his authority,” said Marketplace regular and Washington Post columnist Allan Sloan. “There are 355 pages of this stuff. And that gives you hundreds and hundreds and hundreds of places where somebody can find loopholes.”
Click the above audio player to hear the full interview with Sloan.
We’re here to help you navigate this changed world and economy.
Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.
In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.
Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.
Give today and get our limited edition tote.